• 620 Citations
  • 11 h-Index
20122020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Laurent Calvier is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 0 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 620 Citations
  • 11 h-Index
  • 13 Article
  • 2 Letter
  • 2 Review article

Activation of the metabolic master regulator PPARg: A potential pioneering therapy for pulmonary arterial hypertension

Hansmann, G., Calvier, L., Risbano, M. G. & Chan, S. Y., Jan 1 2020, In : American journal of respiratory cell and molecular biology. 62, 2, p. 143-156 14 p.

Research output: Contribution to journalReview article

  • 1 Scopus citations

    PPARγ is a gatekeeper for extracellular matrix and vascular cell homeostasis: Beneficial role in pulmonary hypertension and renal/cardiac/pulmonary fibrosis

    Kökény, G., Calvier, L., Legchenko, E., Chouvarine, P., Mózes, M. M. & Hansmann, G., Mar 1 2020, In : Current opinion in nephrology and hypertension. 29, 2, p. 171-179 9 p.

    Research output: Contribution to journalReview article

  • 3 Scopus citations

    Chronic TGF-b1 signaling in pulmonary arterial hypertension induces sustained canonical Smad3 pathways in vascular smooth muscle cells

    Calvier, L., Chouvarine, P., Legchenko, E., Kokeny, G., Mozes, M. M. & Hansmann, G., Jan 1 2019, In : American journal of respiratory cell and molecular biology. 61, 1, p. 121-123 3 p.

    Research output: Contribution to journalLetter

    1 Scopus citations

    LRP1 Deficiency in Vascular SMC Leads to Pulmonary Arterial Hypertension That Is Reversed by PPARγ Activation

    Calvier, L., Boucher, P., Herz, J. & Hansmann, G., Jun 7 2019, In : Circulation research. 124, 12, p. 1778-1785 8 p.

    Research output: Contribution to journalArticle

    Open Access
  • 2 Scopus citations

    The PPARγagonist pioglitazone prevents TGF-β induced renal fibrosis by repressing EGR-1 and STAT3

    Németh, Á., Mózes, M. M., Calvier, L., Hansmann, G. & Kökény, G., Jul 5 2019, In : BMC Nephrology. 20, 1, 245.

    Research output: Contribution to journalArticle

    Open Access
  • 4 Scopus citations